Properdin

Properdin is a protein that plays a crucial role in the immune system, specifically in the complement system. It is a positive regulator of the alternative pathway of complement activation, which is one of the three pathways that activate the complement system, an essential part of the innate immune response.
Structure[edit]
Properdin is a glycoprotein composed of multiple subunits. It is known to exist in different oligomeric forms, including dimers, trimers, and tetramers. These oligomeric forms are important for its function in stabilizing the alternative pathway convertase complexes.
Function[edit]
Properdin functions by binding to and stabilizing the C3 and C5 convertase enzyme complexes of the alternative pathway. This stabilization enhances the activity of these complexes, leading to increased cleavage of complement components C3 and C5, and ultimately, the formation of the membrane attack complex (MAC). The MAC is responsible for lysing pathogens and infected cells.
Role in the Alternative Pathway[edit]
The alternative pathway of complement activation is continuously active at a low level, providing a rapid response to pathogens. Properdin is unique among complement proteins because it acts as a positive regulator, enhancing the activity of the pathway. It binds to surfaces of pathogens and damaged cells, promoting the assembly and stability of the C3 convertase (C3bBb) and C5 convertase (C3bBbC3b) complexes.
Clinical Significance[edit]
Deficiencies in properdin can lead to increased susceptibility to infections, particularly those caused by Neisseria meningitidis, a bacterium responsible for meningitis. Conversely, excessive activation of the complement system, potentially involving properdin, can contribute to inflammatory diseases.
Research and Therapeutic Potential[edit]
Research into properdin and its role in the complement system is ongoing, with potential therapeutic applications in modulating the immune response. Targeting properdin may offer strategies for treating diseases involving complement dysregulation, such as autoimmune diseases and age-related macular degeneration.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian